slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 38,221-38,250
Pages 10,126
Rows per page 30
Component
38,221-38,250 of 303,780
56
The slide uses a matrix-like structure to compare three strategic pillars of online retail impact.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations Beat · Satisfaction2 hits
63
Auto Trader Group | Investor Day Presentation Deck | 100 slidesAuto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 2 hits
64
Auto Trader Group | Investor Day Presentation Deck | 100 slidesAuto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 2 hits
72
Auto Trader Group | Investor Day Presentation Deck | 100 slidesAuto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 2 hits
75
The timeline uses a two-row layout with a connector arrow; future milestones are faded out.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 2 hits
77
Auto Trader Group | Investor Day Presentation Deck | 100 slidesAuto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 2 hits
82
The slide uses a grouped bar chart to contrast pre-pandemic and current performance metrics.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations Loop · Quick Win Big Bet2 hits
85
The slide uses a 3-column matrix structure to define the strategic benefits of the merger.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations Loop · Quick Win Big Bet2 hits
87
The slide uses a matrix structure to contrast current performance (FY23) with future goals (mid-term) across four key business metrics.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 2 hits
93
The flywheel shows how retailer/OEM investment leads to more inventory, which attracts consumers, leading to more deals and conversion.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations Beat · Action2 hits
96
The slide uses a tabular structure to explain the decomposition of financial reporting segments.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations Beat · Action2 hits
01
Includes company logo and ticker symbol.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 2 hits
04
The diagram illustrates a hub-and-spoke model showing systemic interaction of EMMs across various organs.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Beat · Propose Solution2 hits
06
The slide uses a three-column structure to frame the problem: Market State, Biological Complexity, and Clinical Need.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Beat · Problem StatementLoop · Cost Of Inaction2 hits
07
The slide uses a timeline framework to show trial progression over time.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction2 hits
08
Axcella Health | Results Presentation Deck | 62 slidesAxcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Beat · Key TakeawaysLoop · Cost Of Inaction2 hits
11
The slide uses a standard clinical trial flow diagram to illustrate study arms and assessment points.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction2 hits
15
The data shows a statistically significant improvement in the high-dose group at Week 24.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction2 hits
16
The slide shows clinical trial data comparing two biomarkers for fibrosis treatment efficacy.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction2 hits
21
DMC = Data Monitoring Committee; TEAE = Treatment Emergent Adverse Event; SAE = Serious Adverse Event.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction2 hits
24
The slide uses a central biological pathway diagram (liver-centric) surrounded by comparative tables showing single-target drugs vs AXA1125's multi-target approach.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction2 hits
25
The slide uses a central biological pathway map (liver/metabolic focus) flanked by comparison tables showing single-target competitors vs AXA1125's multi-target effects.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction2 hits
26
The slide uses bar charts to show dose-dependent increases in metabolic markers and a table to show pathway enrichment scores.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction2 hits
27
The slide uses a pathway diagram and a bar chart to demonstrate the mechanism of action of AXA1125 in a Primary Human Hepatocyte (PHH) Lipotoxicity Model.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction2 hits
28
Includes statistical significance markers (*, **, ***) and experimental methodology in the footer.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction2 hits
29
The slide presents preclinical data from primary human hepatic stellate cells.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction2 hits
38
The slide outlines a clinical trial protocol for AXA1125.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 2 hits
43
The slide compares three groups (Placebo, AXA1125 22.6 BID, AXA1125 33.9 BID) across two time points (Week 12 and Week 24).Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 2 hits
45
The slide title mentions week 12, but the charts explicitly label week 24. This is a common discrepancy in clinical trial decks where data is presented across multiple time points.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 2 hits
47
The slide presents longitudinal data from the REGENERATE trial, specifically focusing on FIB-4 scores as a non-invasive test (NIT) for fibrosis.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 2 hits